Annual EBIT
-$17.45 M
+$18.78 M+51.85%
December 31, 2023
Summary
- As of February 7, 2025, VCYT annual earnings before interest & taxes is -$17.45 million, with the most recent change of +$18.78 million (+51.85%) on December 31, 2023.
- During the last 3 years, VCYT annual EBIT has risen by +$17.23 million (+49.69%).
- VCYT annual EBIT is now -46.33% below its all-time high of -$11.92 million, reached on December 31, 2019.
Performance
VCYT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
$16.85 M
+$9.49 M+128.86%
September 30, 2024
Summary
- As of February 7, 2025, VCYT quarterly earnings before interest & taxes is $16.85 million, with the most recent change of +$9.49 million (+128.86%) on September 30, 2024.
- Over the past year, VCYT quarterly EBIT has increased by +$47.32 million (+155.30%).
- VCYT quarterly EBIT is now at all-time high.
Performance
VCYT Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$8.17 M
+$46.62 M+85.09%
September 30, 2024
Summary
- As of February 7, 2025, VCYT TTM earnings before interest & taxes is -$8.17 million, with the most recent change of +$46.62 million (+85.09%) on September 30, 2024.
- Over the past year, VCYT TTM EBIT has increased by +$68.43 million (+89.34%).
- VCYT TTM EBIT is now -65.39% below its all-time high of -$4.94 million, reached on September 30, 2012.
Performance
VCYT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
VCYT EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +51.9% | +155.3% | +89.3% |
| 3 y3 years | +49.7% | +209.3% | +89.5% |
| 5 y5 years | +17.1% | +2607.3% | +31.5% |
VCYT EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +78.6% | at high | +155.3% | at high | +90.0% |
| 5 y | 5-year | -46.3% | +78.6% | at high | +136.9% | at high | +90.0% |
| alltime | all time | -46.3% | +78.6% | at high | +136.9% | -65.4% | +90.0% |
Veracyte EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $16.85 M(+128.9%) | -$8.17 M(-85.1%) |
| Jun 2024 | - | $7.36 M(-485.8%) | -$54.79 M(-22.2%) |
| Mar 2024 | - | -$1.91 M(-93.7%) | -$70.42 M(-8.1%) |
| Dec 2023 | -$17.45 M(-51.8%) | -$30.47 M(+2.4%) | -$76.60 M(+54.5%) |
| Sep 2023 | - | -$29.77 M(+259.8%) | -$49.56 M(+73.3%) |
| Jun 2023 | - | -$8.27 M(+2.4%) | -$28.61 M(-4.4%) |
| Mar 2023 | - | -$8.08 M(+135.3%) | -$29.91 M(-17.4%) |
| Dec 2022 | -$36.23 M(-55.5%) | -$3.44 M(-61.0%) | -$36.23 M(-17.7%) |
| Sep 2022 | - | -$8.81 M(-8.0%) | -$44.05 M(-13.0%) |
| Jun 2022 | - | -$9.58 M(-33.5%) | -$50.65 M(+0.9%) |
| Mar 2022 | - | -$14.40 M(+28.0%) | -$50.20 M(-38.3%) |
| Dec 2021 | -$81.41 M(+134.7%) | -$11.25 M(-27.0%) | -$81.41 M(+4.2%) |
| Sep 2021 | - | -$15.42 M(+68.9%) | -$78.14 M(+17.0%) |
| Jun 2021 | - | -$9.13 M(-80.0%) | -$66.80 M(-2.7%) |
| Mar 2021 | - | -$45.61 M(+470.8%) | -$68.63 M(+97.9%) |
| Dec 2020 | -$34.68 M(+190.9%) | -$7.99 M(+96.4%) | -$34.68 M(+1.8%) |
| Sep 2020 | - | -$4.07 M(-62.9%) | -$34.07 M(+11.1%) |
| Jun 2020 | - | -$10.96 M(-6.0%) | -$30.67 M(+39.6%) |
| Mar 2020 | - | -$11.66 M(+58.1%) | -$21.97 M(+84.3%) |
| Dec 2019 | -$11.92 M(-43.3%) | -$7.38 M(+997.8%) | -$11.92 M(+67.6%) |
| Sep 2019 | - | -$672.00 K(-70.3%) | -$7.11 M(-31.7%) |
| Jun 2019 | - | -$2.26 M(+40.0%) | -$10.41 M(-25.2%) |
| Mar 2019 | - | -$1.61 M(-37.2%) | -$13.92 M(-33.8%) |
| Dec 2018 | -$21.04 M | -$2.57 M(-35.3%) | -$21.04 M(-18.9%) |
| Sep 2018 | - | -$3.97 M(-31.1%) | -$25.92 M(-8.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | -$5.77 M(-33.9%) | -$28.19 M(-2.5%) |
| Mar 2018 | - | -$8.73 M(+17.1%) | -$28.91 M(+4.8%) |
| Dec 2017 | -$27.60 M(-3.7%) | -$7.46 M(+19.6%) | -$27.60 M(+16.3%) |
| Sep 2017 | - | -$6.23 M(-3.9%) | -$23.74 M(+6.2%) |
| Jun 2017 | - | -$6.49 M(-12.5%) | -$22.34 M(-15.1%) |
| Mar 2017 | - | -$7.42 M(+106.2%) | -$26.31 M(-8.2%) |
| Dec 2016 | -$28.65 M(-14.0%) | -$3.60 M(-25.7%) | -$28.65 M(-13.1%) |
| Sep 2016 | - | -$4.84 M(-53.7%) | -$32.96 M(-10.9%) |
| Jun 2016 | - | -$10.46 M(+7.2%) | -$36.97 M(+4.0%) |
| Mar 2016 | - | -$9.76 M(+23.5%) | -$35.56 M(+6.7%) |
| Dec 2015 | -$33.33 M(+15.2%) | -$7.90 M(-10.7%) | -$33.32 M(-0.4%) |
| Sep 2015 | - | -$8.85 M(-2.1%) | -$33.46 M(+3.3%) |
| Jun 2015 | - | -$9.05 M(+20.3%) | -$32.40 M(+8.4%) |
| Mar 2015 | - | -$7.52 M(-6.5%) | -$29.89 M(+3.3%) |
| Dec 2014 | -$28.93 M(+14.2%) | -$8.04 M(+3.2%) | -$28.93 M(+8.4%) |
| Sep 2014 | - | -$7.79 M(+19.0%) | -$26.68 M(+6.4%) |
| Jun 2014 | - | -$6.54 M(-0.3%) | -$25.07 M(+0.2%) |
| Mar 2014 | - | -$6.56 M(+13.4%) | -$25.02 M(-1.3%) |
| Dec 2013 | -$25.35 M(+35.9%) | -$5.79 M(-6.3%) | -$25.35 M(+3.9%) |
| Sep 2013 | - | -$6.18 M(-4.7%) | -$24.39 M(+5.4%) |
| Jun 2013 | - | -$6.49 M(-5.9%) | -$23.16 M(+38.9%) |
| Mar 2013 | - | -$6.89 M(+42.5%) | -$16.67 M(+70.5%) |
| Dec 2012 | -$18.65 M(+29.1%) | -$4.84 M(-2.0%) | -$9.78 M(+98.0%) |
| Sep 2012 | - | -$4.94 M | -$4.94 M |
| Dec 2011 | -$14.45 M | - | - |
FAQ
- What is Veracyte annual earnings before interest & taxes?
- What is the all time high annual EBIT for Veracyte?
- What is Veracyte annual EBIT year-on-year change?
- What is Veracyte quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Veracyte?
- What is Veracyte quarterly EBIT year-on-year change?
- What is Veracyte TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Veracyte?
- What is Veracyte TTM EBIT year-on-year change?
What is Veracyte annual earnings before interest & taxes?
The current annual EBIT of VCYT is -$17.45 M
What is the all time high annual EBIT for Veracyte?
Veracyte all-time high annual earnings before interest & taxes is -$11.92 M
What is Veracyte annual EBIT year-on-year change?
Over the past year, VCYT annual earnings before interest & taxes has changed by +$18.78 M (+51.85%)
What is Veracyte quarterly earnings before interest & taxes?
The current quarterly EBIT of VCYT is $16.85 M
What is the all time high quarterly EBIT for Veracyte?
Veracyte all-time high quarterly earnings before interest & taxes is $16.85 M
What is Veracyte quarterly EBIT year-on-year change?
Over the past year, VCYT quarterly earnings before interest & taxes has changed by +$47.32 M (+155.30%)
What is Veracyte TTM earnings before interest & taxes?
The current TTM EBIT of VCYT is -$8.17 M
What is the all time high TTM EBIT for Veracyte?
Veracyte all-time high TTM earnings before interest & taxes is -$4.94 M
What is Veracyte TTM EBIT year-on-year change?
Over the past year, VCYT TTM earnings before interest & taxes has changed by +$68.43 M (+89.34%)